The Joint Commission

[HAP Large] Acute Care Hospitals that do not provide Obstetrical Services (2022)


CY2022 ORYX Requirements for [HAP Large] Acute Care Hospitals that DO NOT provide Obstetrical Services


How are [HAP Large] Acute Care Hospitals defined as it relates to ORYX Requirements?

For The Joint Commission, ORYX performance measurement requirements are specifically applicable to organizations accredited under the Hospital Accreditation Program (HAP).

HAP Large are defined as ≥26 Licensed beds OR ≥ 50,000 Outpatient visits

Refer to your Joint Commission Connect Site eAPP Hospital Volume or view the DDSP HCO Characteristics Organization Requirements tab for licensed bed / outpatient volume information.


  • eCQMs are submitted for three (3) quarters.

  • Chart-abstracted measures are submitted for four (4) quarters. unless otherwise noted.

  • In order to meet ORYX requirements, submitted measures must be applicable to patient population/services offered.

[HAP Large] Hospitals with ≥ 26 Licensed beds OR ≥ 50,000 Outpatient visits AND Provide Obstetrical Services

[HAP Large] Hospitals with ≥ 26 Licensed beds OR ≥ 50,000 Outpatient visits AND Provide Obstetrical Services

AVAILABLE: Your hospital must submit a minimum of four(4) eCQMs from those listed below:

eED-2 (eCQM) Admit Decision Time to ED Departure-Admit

eOPI-1 (eCQM) Safe Use of Opioids

ePC-07 (eCQM) Severe Obstetric Complications

eSTK-2 (eCQM) Discharged on Antithrombotic Therapy

eSTK-3 (eCQM) Anticoagulation Therapy Atrial Fibrillation/Flutter

eSTK-5 (eCQM) Antithrombotic Therapy by End of Hospital Day 2

eSTK-6 (eCQM) Discharged on Statin Medication

eVTE-1 (eCQM) Venous Thromboembolism Prophylaxis

eVTE-2 (eCQM) ICU Venous Thromboembolism Prophylaxis

OPTIONAL Chart-Abstracted Measures

ED-1 (CAM) Median ED Arrival to ED Departure-Admit

ED-2 (CAM) Admit Decision Time to ED Departure-Admit

HBIPS-1 (CAM) Admission Screening

HBIPS-2 (CAM) Hours of Physical Restraint Use

HBIPS-3 (CAM) Hours of Seclusion Use

HBIPS-5 (CAM) Antipsychotic Medications at Discharge

IMM-2 (CAM) Influenza Immunization

NOTE: IMM-2 is a seasonal measure; only 1Q and 4Q data are submitted

OP-18 (CAM) Median ED Arrival-ED Departure at Discharge

OP-23 (CAM) Head CT or MRI Scan Results-Stroke

SUB-2 (CAM) Alcohol Use Brief Intervention

SUB-3 (CAM) Alcohol & Drug Use Treatment at Discharge

TOB-2 (CAM) Tobacco Use Treatment

TOB-3 (CAM) Tobacco Use Treatment at Discharge

VTE-6 (CAM) Hospital Acquired Potentially-Preventable VTE 

 

©The Joint Commission, All Rights Reserved
The Joint Commission is a registered trademark of The Joint Commission.